drugset / Trial / NCT00352742
A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to describe the safety and effect of ATN-224 in combination with bortezomib (Velcade®) in patients with Multiple Myeloma who are relapsed from or refractory to bortezomib.
Timeline
- Start
- 2006-06
- Primary completion
- 2008-09
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TIOMOLIBDATE CHOLINE | Small molecule | — | — |
| Background | Bortezomib | Small molecule | — | — |